Acrivon Therapeutics, Inc. Common Stock (ACRV) vs Nutriband Inc. (NTRB)

A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and Nutriband Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACRV vs NTRB

growth of $100 · dividends reinvested · last 4y
ACRV -88.1% (-41.3%/yr)NTRB +66.0% (+13.5%/yr)NTRB compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002023202420252026$12$166
ACRV NTRB

ACRV vs NTRB: by the numbers

  • •NTRB is the larger company ($82M vs $81M market cap).
  • •Both run net losses; ACRV's is the smaller (0.00% vs -430.43% net margin).

Metrics side by side

Valuation

MetricACRVNTRB
Forward P/EN/A4.27
P/S ratioN/A50.42
P/B ratio0.9315.32

Profitability

MetricACRVNTRB
Gross margin0.00%33.14%
Operating margin0.00%-408.41%
Net margin0.00%-430.43%
ROE-85.65%-130.67%
ROIC-88.28%-126.99%

Growth (annualized)

MetricACRVNTRB
Revenue CAGR (5Y)N/A3.12%
Total return CAGR (5Y)N/A6.67%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.